Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 485689, 10 pages
http://dx.doi.org/10.1155/2014/485689
Research Article

Freeze-Drying of Plant Tissue Containing HBV Surface Antigen for the Oral Vaccine against Hepatitis B

1Institute of Plant Genetics, Polish Academy of Sciences, Strzeszyńska 34, 60-479 Poznań, Poland
2Poznań University of Life Sciences, Wojska Polskiego 28, 60-995 Poznań, Poland
3Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wrocław, Poland

Received 16 May 2014; Revised 11 September 2014; Accepted 17 September 2014; Published 12 October 2014

Academic Editor: Héla Kallel

Copyright © 2014 Marcin Czyż et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Kew, “Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma,” Pathologie Biologie, vol. 58, no. 4, pp. 273–277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Romano', S. Paladini, P. van Damme, and A. R. Zanetti, “The worldwide impact of vaccination on the control and protection of viral hepatitis B,” Digestive and Liver Disease, vol. 43, supplement 1, pp. S2–S7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Kostrzak, M. Cervantes Gonzalez, D. Guetard et al., “Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells,” Vaccine, vol. 27, no. 35, pp. 4798–4807, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Pniewski, J. Kapusta, P. Bociag et al., “Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation,” Journal of Applied Genetics, vol. 52, no. 2, pp. 125–136, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Pniewski, J. Kapusta, P. Bociag et al., “Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation,” Plant Cell Reports, vol. 31, no. 3, pp. 585–595, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. M.-L. Michel and P. Tiollais, “Hepatitis B vaccines: protective efficacy and therapeutic potential,” Pathologie Biologie, vol. 58, no. 4, pp. 288–295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Diminsky, N. Moav, M. Gorecki, and Y. Barenholz, “Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles,” Vaccine, vol. 18, no. 1-2, pp. 3–17, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Franks, “Freeze-drying of bioproducts: putting principles into practice,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 45, no. 3, pp. 221–229, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Tang and M. J. Pikal, “Design of freeze-drying processes for pharmaceuticals: practical advice,” Pharmaceutical Research, vol. 21, no. 2, pp. 191–200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Wang, “Lyophilization and development of solid protein pharmaceuticals,” International Journal of Pharmaceutics, vol. 203, no. 1-2, pp. 1–60, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Lang, G. Winter, L. Vogt, A. Zürcher, B. Dorigo, and B. Schimmele, “Rational design of a stable, freeze-dried virus-like particle-based vaccine formulation,” Drug Development and Industrial Pharmacy, vol. 35, no. 1, pp. 83–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Q. Sun, A. C. Leopold, L. M. Crowe, and J. H. Crowe, “Stability of dry liposomes in sugar glasses,” Biophysical Journal, vol. 70, no. 4, pp. 1769–1776, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. J. J. Schwegman, L. M. Hardwick, and M. J. Akers, “Practical formulation and process development of freeze-dried products,” Pharmaceutical Development and Technology, vol. 10, no. 2, pp. 151–173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Yu, “Amorphous pharmaceutical solids: preparation, characterization and stabilization,” Advanced Drug Delivery Reviews, vol. 48, no. 1, pp. 27–42, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. J. Garmise, K. Mar, T. M. Crowder et al., “Formulation of a dry powder influenza vaccine for nasal delivery,” AAPS PharmSciTech, vol. 7, no. 1, pp. E131–E137, 2006. View at Publisher · View at Google Scholar
  16. Y.-F. Maa, M. Ameri, C. Shu, L. G. Payne, and D. Chen, “Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation,” Journal of Pharmaceutical Sciences, vol. 93, no. 7, pp. 1912–1923, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Slade and H. Levine, “Beyond water activity: recent advances based on an alternative approach to the assessment of food quality and safety,” Critical reviews in food science and nutrition, vol. 30, no. 2-3, pp. 115–360, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. J. F. Carpenter, S. J. Prestrelski, and T. Arakawa, “Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization: I. Enzyme activity and calorimetric studies,” Archives of Biochemistry and Biophysics, vol. 303, no. 2, pp. 456–464, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. J. F. Carpenter and J. H. Crowe, “An infrared spectroscopic study of the interactions of carbohydrates with dried proteins,” Biochemistry, vol. 28, no. 9, pp. 3916–3922, 1989. View at Publisher · View at Google Scholar · View at Scopus
  20. J. F. Carpenter, T. Arakawa, and J. H. Crowe, “Interactions of stabilizing additives with proteins during freeze-thawing and freeze-drying,” Developments in Biological Standardization, vol. 74, pp. 225–238, 1992. View at Google Scholar · View at Scopus
  21. L. Chang, D. Shepherd, J. Sun et al., “Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix?” Journal of Pharmaceutical Sciences, vol. 94, no. 7, pp. 1427–1444, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. C. May, R. M. Wheeler, and E. Grim, “The gravimetric method for the determination of residual moisture in freeze-dried biological products,” Cryobiology, vol. 26, no. 3, pp. 277–284, 1989. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Cao, Y. Chen, Z. Cui, and P. R. Foster, “Effect of freezing and thawing rates on denaturation of proteins in aqueous solutions,” Biotechnology and Bioengineering, vol. 82, no. 6, pp. 684–690, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. E. C. A. van Winden, W. Zhang, and D. J. A. Crommelin, “Effect of freezing rate on the stability of liposomes during freeze-drying and rehydration,” Pharmaceutical Research, vol. 14, no. 9, pp. 1151–1160, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Rathore and R. S. Rajan, “Current perspectives on stability of protein drug products during formulation, fill and finish operations,” Biotechnology Progress, vol. 24, no. 3, pp. 504–514, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. A. Searles, J. F. Carpenter, and T. W. Randolph, “The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf,” Journal of Pharmaceutical Sciences, vol. 90, no. 7, pp. 860–871, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. P. J. Dawson and D. J. Hockley, “Scanning electron microscopy of freeze-dried preparations: relationship of morphology to freeze-drying parameters,” Developments in Biological Standardization, vol. 74, pp. 185–192, 1992. View at Google Scholar · View at Scopus
  28. M. J. Pikal, S. Shah, D. Senior, and J. E. Lang, “Physical chemistry of freeze-drying: measurement of sublimation rates for frozen aqueous solutions by a microbalance technique,” Journal of Pharmaceutical Sciences, vol. 72, no. 6, pp. 635–650, 1983. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Oguchi, E. Yonemochi, K. Yamamoto, and Y. Nakai, “Freeze drying of drug additive binary systems i. effects of freezing condition on the crystallinity,” Chemical and Pharmaceutical Bulletin, vol. 37, no. 7, pp. 1881–1885, 1989. View at Google Scholar · View at Scopus
  30. C. C. Hsu, H. M. Nguyen, D. A. Yeung et al., “Surface denaturation at solid-void interface: a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures,” Pharmaceutical Research, vol. 12, no. 1, pp. 69–77, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Sarciaux, S. Mansour, M. J. Hageman, and S. L. Nail, “Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying,” Journal of Pharmaceutical Sciences, vol. 88, no. 12, pp. 1354–1361, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. B. S. Chang, B. S. Kendrick, and J. F. Carpenter, “Surface-induced denaturation of proteins during freezing and its inhibition by surfactants,” Journal of Pharmaceutical Sciences, vol. 85, no. 12, pp. 1325–1330, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Jiang and S. L. Nail, “Effect of process conditions on recovery of protein activity after freezing and freeze-drying,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 45, no. 3, pp. 249–257, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. L. V. Gusta, M. Wisniewski, N. T. Nesbitt, and M. L. Gusta, “The effect of water, sugars, and proteins on the pattern of ice nucleation and propagation in acclimated and nonacclimated canola leaves,” Plant Physiology, vol. 135, no. 3, pp. 1642–1653, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Huang, J. Nicodemus, D. G. Zarka, M. F. Thomashow, M. Wisniewski, and J. G. Duman, “Expression of an insect (Dendroides canadensis) antifreeze protein in Arabidopsis thaliana results in a decrease in plant freezing temperature,” Plant Molecular Biology, vol. 50, no. 3, pp. 333–344, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Hacker and G. Neuner, “Ice propagation in plants visualized at the tissue level by infrared differential thermal analysis (IDTA),” Tree Physiology, vol. 27, no. 12, pp. 1661–1670, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. G. John Morris and E. Acton, “Controlled ice nucleation in cryopreservation—a review,” Cryobiology, vol. 66, no. 2, pp. 85–92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. M. C. Heller, J. F. Carpenter, and T. W. Randolph, “Protein formulation and lyophilization cycle design: prevention of damage due to freeze-concentration induced phase separation,” Biotechnology and Bioengineering, vol. 63, no. 2, pp. 166–174, 1999. View at Publisher · View at Google Scholar
  39. V. Bruss, “Hepatitis B virus morphogenesis,” World Journal of Gastroenterology, vol. 13, no. 1, pp. 65–73, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. D. B. Varshney, S. Kumar, E. Y. Shalaev et al., “Glycine crystallization in frozen and freeze-dried systems: effect of pH and buffer concentration,” Pharmaceutical Research, vol. 24, no. 3, pp. 593–604, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. J. F. Carpenter, J. H. Crowe, and T. Arakawa, “Comparison of solute-induced protein stabilization in aqueous-solution and in the frozen and dried states,” Journal of Dairy Science, vol. 73, no. 12, pp. 3627–3636, 1990. View at Publisher · View at Google Scholar
  42. J. S. Liu, “Physical characterization of pharmaceutical formulations in frozen and freeze-dried solid states: techniques and applications in freeze-drying development,” Pharmaceutical Development and Technology, vol. 11, no. 1, pp. 3–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Pniewski, “The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects?” International Journal of Molecular Sciences, vol. 14, no. 1, pp. 1978–1998, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. M. J. Pikal, “Freeze-drying of proteins. Part I: process design,” BioPharm, vol. 3, pp. 18–28, 1990. View at Google Scholar
  45. M. J. Pikal, “Freeze-drying of proteins part II: formulation selection,” BioPharm, vol. 3, pp. 26–30, 1990. View at Google Scholar
  46. J. K. Towns, “Moisture content in proteins: its effects and measurement,” Journal of Chromatography A, vol. 705, no. 1, pp. 115–127, 1995. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Y. Shalaev and G. Zografi, “How does residual water affect the solid-state degradation of drugs in the amorphous state?” Journal of Pharmaceutical Sciences, vol. 85, no. 11, pp. 1137–1141, 1996. View at Publisher · View at Google Scholar · View at Scopus
  48. M. J. Pikal, M. L. Roy, and S. Shah, “Mass and heat transfer in vial freeze-drying of pharmaceuticals: role of the vial,” Journal of Pharmaceutical Sciences, vol. 73, no. 9, pp. 1224–1237, 1984. View at Publisher · View at Google Scholar · View at Scopus
  49. M. J. Pikal and J. E. Lang, “Rubber closures as a source of haze in freeze dried parenterals: test methodology for closure evaluation,” Journal of the Parenteral Drug Association, vol. 32, no. 4, pp. 162–173, 1978. View at Google Scholar · View at Scopus
  50. W. Y. Kuu, L. M. Hardwick, and M. J. Akers, “Correlation of laboratory and production freeze drying cycles,” International Journal of Pharmaceutics, vol. 302, no. 1-2, pp. 56–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Kramer, D. M. Kremer, M. J. Pikal, W. J. Petre, E. Y. Shalaev, and L. A. Gatlin, “A procedure to optimize scale-up for the primary drying phase of lyophilization,” Journal of Pharmaceutical Sciences, vol. 98, no. 1, pp. 307–318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. Q. Kong, L. Richter, Y. F. Yang, C. J. Arntzen, H. S. Mason, and Y. Thanavala, “Oral immunization with hepatitis B surface antigen expressed in transgenic plants,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 20, pp. 11539–11544, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. C. A. Hayden, S. J. Streatfield, B. J. Lamphear et al., “Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen,” Vaccine, vol. 30, no. 19, pp. 2937–2942, 2012. View at Publisher · View at Google Scholar · View at Scopus